Evidence map›Paper›PMID 34041041›Full record

ArticleFrontiers in cellular and infection microbiology2021

16S rDNA Full-Length Assembly Sequencing Technology Analysis of Intestinal Microbiome in Polycystic Ovary Syndrome.

Sitong Dong, Jiao Jiao, Shuangshuo Jia, Gaoyu Li, Wei Zhang, Kai Yang, Zhen Wang, Chao Liu, Da Li, Xiuxia Wang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 5 pooled it
3.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 5 syntheses or guidelines pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Sitong DongCenter of Reproductive Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
Jiao JiaoCenter of Reproductive Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
Shuangshuo JiaDepartment of Orthopedic Surgery, Shengjing Hospital of China Medical University, Shenyang, China.
Gaoyu LiCenter of Reproductive Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
Wei ZhangCenter of Reproductive Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
Kai YangDepartment of Research and Development, Germountx Company, Beijing, China.
Zhen WangDepartment of Research and Development, Germountx Company, Beijing, China.
Chao LiuDepartment of Biological Information, Kangwei Medical Analysis Laboratory, Shenyang, China.
Da LiCenter of Reproductive Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
Xiuxia WangCenter of Reproductive Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To study the characteristics and relationship of the gut microbiota in patients with polycystic ovary syndrome (PCOS). Method: We recruited 45 patients with PCOS and 37 healthy women from the Reproductive Department of Shengjing Hospital. We recorded their clinical indexes, and sequenced their fecal samples by 16S rDNA full-length assembly sequencing technology (16S-FAST). Result: We found decreased α diversity and different abundances of a series of microbial species in patients with PCOS compared to healthy controls. We found LH and AMH were significantly increased in PCOS with Conclusion: Our study found gut microbiota that had different abundance in patients with PCOS compared to healthy controls. An intimate relationship was shown between the gut microbiota and pathological changes in PCOS. We suggest the gut microbiota should be taken into consideration in the treatment of symptoms of PCOS

Indexed as

Gastrointestinal MicrobiomePolycystic Ovary SyndromeDNA, RibosomalEubacterialesFemaleHumansPrevotellaTechnologyVeillonellaceaeDNA, Ribosomal16S-FASTenterotypeinsulin resistanceintestinal microbiomeoverweightPCOS (polycystic ovarian syndrome)

Identifiers

PMID34041041
PMCPMC8141595
OpenAlexW3163640835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.